News Releases

Form S-4 approved by the U.S. Securities and Exchange Commission and now effective Spectral MD posting circular ahead of a general meeting to approve business combination with Rosecliff   LONDON, U.K. AND DALLAS, TX, U.S . -Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI)

  LONDON, U.K. AND DALLAS, TX, U.S.  -Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, announces that it has released a short investor video further to the  recent update

  LONDON, U.K. AND DALLAS, TX, U.S – Spectral MD Holdings, Ltd. (AIM: SMD) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, announces that it has received ISO 13485 certification for the manufacture and

Rosecliff to hold special meeting to approve the Transaction on September 6, 2023 LONDON, U.K. AND DALLAS, TX, U.S.  -Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, notes

  LONDON, U.K. AND DALLAS, TX, U.S. – Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, notes that Rosecliff Acquisition Corp I (“Rosecliff”, Nasdaq: RCLF) has filed on August

  As stated in the announcement on April 11, 2023, detailing the planned business combination (the “Transaction”) with Rosecliff Acquisition Corp I (“Rosecliff”), the Board of Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster

  LONDON, U.K. AND DALLAS, TX, U.S . -Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, notes that Rosecliff Acquisition Corp I (“Rosecliff”, Nasdaq: RCLF) has filed on 8

LONDON, U.K. AND DALLAS, TX, U.S.  -Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, has issued an updated corporate presentation (“Corporate Presentation”) to be consistent

Unaudited results for the Quarter Ended 31 March 2023 Filing of Updated Form S-4 by Rosecliff Acquisition Corp I LONDON, U.K. AND DALLAS, TX, U.S . -Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment

LONDON, U.K. AND DALLAS, TX, U.S. –  Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, notes that Spectral MD is making available a corporate presentation (“Corporate